Ideal Implant Structured Breast Implants Help Women Feel Beautiful and Secure
May 14, 2020
The IDEAL IMPLANT® Structured Breast Implant is a new type of implant designed to look and feel natural — without the risk of silent rupture.
In the past, women seeking breast implants were forced to choose between the peace of mind of saline, which is considered a safe choice, or silicone gel, which offers a more realistic and natural look. However, Ideal Implant Structured Breast Implants feature next-generation technology offering benefits of both, so women can feel beautiful and secure.
Furthermore, when considering breast implants, women want a beautiful, natural result that doesn’t leave them wondering whether their implant has ruptured silently. That’s where Ideal Implant comes in, featuring a beautiful look and natural feel with the safety of only saline inside.
Inspired by women’s concerns, Ideal Implant Structured Breast Implants feature a series of implant shells nested together, along with two separate chambers that hold the saline. Though the implants are constructed with standard materials, Ideal Implant uses an advanced internal structure to control the movement of the saline and support the implant edges to reduce collapse and wrinkling.
Ideal Implant has undergone 10 years of development, testing, and refinement, including contributions of clinical expertise from many board-certified plastic surgeons. Ideal Implant was approved by both the FDA and Health Canada in 2014.
Women deserve peace of mind without compromise. With Ideal Implant, you can look in the mirror and be confident your implants are intact. So now, stay tuned as we discover and discuss the many benefits of Ideal Implant with board-certified plastic surgeons, Constance Barone, M.D. and Claire Duggal, M.D.
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.